Emily Sims, MD

Articles

Challenges in Managing Type 1 Diabetes and Pressing Need for New Therapies

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE;Emily Sims, MD

February 3rd 2023

Drs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes

Potential of CGM and other Technology to Screen for Type 1 Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE;Emily Sims, MD

February 3rd 2023

Expert healthcare practitioners discuss the potential of CGM and other technology to identify signs of type 1 diabetes.

Study Design and Key Findings from Teplizumab Clinical Trials in Type 1 Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE;Emily Sims, MD

February 3rd 2023

Dr Emily Sims reviews the study design of the clinical trials with teplizumab and shares key findings from the completed phase 2 trial.

Stages of Type 1 Diabetes and Mechanism of Action of Teplizumab

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE;Emily Sims, MD

February 3rd 2023

Dr Emily Sims provides an overview of the stages of type 1 diabetes (T1D) and explains how teplizumab slows the immune-mediated destruction of beta cells.